Kanishk Kumar – Hemophilia A Pipeline 2025: New Therapies Changing Patient Care
Kanishk Kumar, Digital Marketing Executive at DelveInsight Business Research LLP, posted on LinkedIn:
“Hemophilia A Pipeline 2025: New Therapies Changing Patient Care
The Hemophilia A treatment landscape is evolving fast in 2025. Researchers and companies are pushing forward gene therapies, long-acting factor replacements, and innovative prophylactic options, all aimed at improving patients’ quality of life and reducing the burden of frequent treatments.
Recent Highlights:
On 10 October 2025, Roche initiated a Phase I/II study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NXT007 in patients with severe or moderate Hemophilia A.
On 08 October 2025, BioMarin Pharmaceutical Inc. announced a Phase III study to assess the safety and effectiveness of valoctocogene roxaparvovec in combination with prophylactic corticosteroids in patients with severe Hemophilia A.
Key companies leading the way include Roche, Chugai Pharmaceutical Co., Ltd. , Shire , Pfizer , BioMarin Pharmaceutical Inc., Sinocelltech Ltd., Bayer, Ultragenyx , Spark Therapeutics, Inc., Octapharma, APCINTEX LIMITED , Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Expression Therapeutics, Inc., CSL and others.”
See the full Hemophilia A Pipeline 2025 report and track the therapies shaping the future here.
Stay updated with Hemostasis Today.
-
Jul 16, 2026, 12:30Amihai Rottenstreich: Women’s Health and Multidisciplinary Care Lead ISTH 2026 Discussions
-
Jul 16, 2026, 12:19Floor Heubel-Moenen: Maastricht Team Highlights BDUC Research at ISTH 2026
-
Jul 16, 2026, 12:11Claire Whyte: ISTH 2026 Highlights Advances in Thrombosis and Hemostasis Research
-
Jul 16, 2026, 12:07Bruno Pougault: ISTH 2026 Paris Highlights – Looking Ahead
-
Jul 16, 2026, 11:46George Tarpley: Sysmex Unveils Next-Generation Coagulation Solutions at ISTH 2026
-
Jul 16, 2026, 07:33Amna Ahmed: An Incredible Experience Sharing My BDUC Research at ISTH 2026 in Paris
-
Jul 16, 2026, 07:33Carsten Deppermann: Already Looking Forward to Meeting the Community Next Year in Vancouver
-
Jul 16, 2026, 07:32Darine Ghanem: Shaping the Future of Hemophilia A Care Together at ISTH 2026
-
Jul 16, 2026, 00:20Mettine Bos: Reflecting on a Fantastic ISTH 2026 in Paris with Team Leiden